{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:40:03Z","timestamp":1791092403612,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.mce.2003.10.009","type":"journal-article","created":{"date-parts":[[2003,11,15]],"date-time":"2003-11-15T12:00:40Z","timestamp":1068897640000},"page":"53-58","source":"Crossref","is-referenced-by-count":93,"title":["Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies"],"prefix":"10.1016","volume":"217","author":[{"given":"Bertram","family":"Pitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2003.10.009_BIB1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0735-1097(01)01729-6","article-title":"Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction role of vascular superoxide anion formation and endothelial nitric oxide synthase expression","volume":"39","author":"Bauersachs","year":"2002","journal-title":"J. Am. College Cardiol."},{"key":"10.1016\/j.mce.2003.10.009_BIB2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1210\/jc.85.1.336","article-title":"Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production","volume":"85","author":"Brown","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2003.10.009_BIB3","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1046\/j.1523-1755.2000.00983.x","article-title":"Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology","volume":"57","author":"Delyani","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.mce.2003.10.009_BIB4","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2003.10.009_BIB5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.37.2.787","article-title":"Mineralcorticoid receptor affects AP-1 and nuclear factor-{kappa} B activation in angiotensin II-induced cardiac injury","volume":"37","author":"Fiebeler","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2003.10.009_BIB6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.mce.2003.10.009_BIB7","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1210\/endo-125-4-2224","article-title":"Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors","volume":"125","author":"Funder","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2003.10.009_BIB8","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1161\/hc4801.100077","article-title":"Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11{beta}-hydroxysteroid dehydrogenase","volume":"104","author":"Hadoke","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2003.10.009_BIB9","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/01.HYP.33.5.1179","article-title":"11-Beta-hydroxysteroid dehydrogenase in cultured human vascular cells. Possible role in the development of hypertension","volume":"33","author":"Hatakeyama","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.mce.2003.10.009_BIB10","first-page":"41","article-title":"Identification and role of aldosterone receptors in the cardiovascular system","volume":"61","author":"Lombes","year":"2000","journal-title":"Ann. Endocrinol."},{"key":"10.1016\/j.mce.2003.10.009_BIB11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0008-6363(97)00091-6","article-title":"Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients","volume":"35","author":"MacFadyen","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mce.2003.10.009_BIB12","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.CIR.100.10.1056","article-title":"Comparsion of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot study Investigators","volume":"100","author":"McKelvie","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2003.10.009_BIB13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1067\/mhj.2001.111258","article-title":"Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction","volume":"141","author":"Modena","year":"2001","journal-title":"Am. Heart J."},{"key":"10.1016\/j.mce.2003.10.009_BIB14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.mce.2003.10.009_BIB15","first-page":"23A","article-title":"Efficacy and safety of eplerenone, enalapril, and eplerenone\/enalapril combination therapy in patients with left ventricular hypertrophy","volume":"15","author":"Pitt","year":"2002","journal-title":"AJH"},{"key":"10.1016\/j.mce.2003.10.009_BIB16","doi-asserted-by":"crossref","unstructured":"Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., Gatlin, M., 2003. For the eplerenone post-acute myocardial infarction heart failure efficacy and survival study investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348 (14) 1309\u20131321.","DOI":"10.1056\/NEJMoa030207"},{"key":"10.1016\/j.mce.2003.10.009_BIB17","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000015854.60710.10","article-title":"Mineralocorticoid receptor antagonism in experimental atherosclerosis","volume":"105","author":"Rajagopalan","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2003.10.009_BIB18","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1161\/01.CIR.0000039104.56479.42","article-title":"Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure","volume":"106","author":"Suzuki","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.mce.2003.10.009_BIB19","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0735-1097(01)01243-8","article-title":"Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure","volume":"37","author":"Yee","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.mce.2003.10.009_BIB20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2003.10.009_BIB21","doi-asserted-by":"crossref","first-page":"H423","DOI":"10.1152\/ajpheart.00685.2001","article-title":"The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure","volume":"283","author":"Zhang","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720703003800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720703003800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T02:00:52Z","timestamp":1550368852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720703003800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":21,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0303720703003800"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2003.10.009","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}